Podcast Episodes
Back to Search
Navigating Trump’s tariffs for pharma
After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other ou…
1 year, 2 months ago
Q1 biopharma layoff trends, plus expectations for Q2
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson discuss how workforce re…
1 year, 2 months ago
A closer look at pharma's top R&D budgets
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fie…
1 year, 3 months ago
What diversity means in medtech
Since the first days of the new Trump administration, the White House has handed down orders to ban work focused on diversity, equity and inclusion (…
1 year, 3 months ago
5 Key Questions About Precision Patient Marketing—Answered (Sponsored)
In this episode of The Top Line, sponsored by PatientPoint, Andrew Schultz, President of PatientPoint Precision, discusses how hypertargeting and con…
1 year, 3 months ago
A closer look at pharma’s top patent losses in 2025
Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new biosimilars or generics in 2025, …
1 year, 3 months ago
Agenus CMO touts immunotherapy advances on The Top Line
Agenus Chief Medical Officer Dr. Steven O'Day joined Fierce's Chris Hayden on a recent sponsored episode of The Top Line podcast to discuss the evolv…
1 year, 3 months ago
Breaking down pharma’s fourth-quarter sales boom
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global pharma companies record …
1 year, 3 months ago
Inside the Future of Aseptic Manufacturing with GRAM (Sponsored)
In the latest episode of The Top Line, Chris Hayden of Fierce Pharma sits down with Mary Lou Glotzbach, senior manager of drug delivery partnerships …
1 year, 4 months ago
Bridging the gap from clinical trials to real-life HIV care (Sponsored)
The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical …
1 year, 4 months ago